Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
US Department of Justice
Deloitte
Chubb
Chinese Patent Office
Cerilliant
Moodys
McKinsey
US Army

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050689

« Back to Dashboard

NDA 050689 describes MYCOBUTIN, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from three suppliers. Additional details are available on the MYCOBUTIN profile page.

The generic ingredient in MYCOBUTIN is rifabutin. There are three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the rifabutin profile page.
Summary for 050689
Tradename:MYCOBUTIN
Applicant:Pharmacia And Upjohn
Ingredient:rifabutin
Patents:0
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 050689
Ingredient-typeRifamycins
Medical Subject Heading (MeSH) Categories for 050689
Suppliers and Packaging for NDA: 050689
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MYCOBUTIN rifabutin CAPSULE;ORAL 050689 NDA Pharmacia and Upjohn Company LLC 0013-5301 N 0013-5301-17
MYCOBUTIN rifabutin CAPSULE;ORAL 050689 NDA Department of State Health Services, Pharmacy Branch 55695-010 N 55695-010-00

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength150MG
Approval Date:Dec 23, 1992TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fuji
Colorcon
Healthtrust
Medtronic
UBS
Cipla
Dow
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.